Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 1 of 1
Full-Text Articles in Medicine and Health Sciences
Gonadotrophin Releasing Hormone Agonist With Low Dose Human Chorionic Gonadotrophin Co-Triggers Versus Gonadotrophin Releasing Hormone Agonist Alone For Reducing The Risk Of Ovarian Hyperstimulation In Women With Polycystic Ovarian Disease., Ahmed Arafa, Mofeed Mohamed, Ahmed Aboulserour, Mohamed Gebreel
Gonadotrophin Releasing Hormone Agonist With Low Dose Human Chorionic Gonadotrophin Co-Triggers Versus Gonadotrophin Releasing Hormone Agonist Alone For Reducing The Risk Of Ovarian Hyperstimulation In Women With Polycystic Ovarian Disease., Ahmed Arafa, Mofeed Mohamed, Ahmed Aboulserour, Mohamed Gebreel
Al-Azhar International Medical Journal
Background: “Dual triggering” for final oocyte maturation using acombination of a gonadotropin-releasing hormone agonist (GnRHa) and human chorionic gonadotropin (hCG) can improve clinical outcomes in high responders during in vitro fertilization–intracytoplasmic sperm injection (IVF–ICSI) GnRH-antagonist cycles. Aim of the work: To compare gonadotrophin releasing hormone agonist with low dose human chorionic gonadotrophin co-triggers versus gonadotrophin releasing hormone agonist alone for reducing the threat of severe ovarian hyperstimulation in women suffering polycystic ovarian disease correlated with outcomes. Patients and methods: There were 120 infertile women who joined the ART department at the International Islamic Center for Population Studies and Research (IICPSR) …